Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
116M
-
Shares change
-
+4.63M
-
Total reported value, excl. options
-
$3.51B
-
Value change
-
+$131M
-
Put/Call ratio
-
4.46
-
Number of buys
-
101
-
Number of sells
-
-114
-
Price
-
$30.30
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q2 2023
264 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q2 2023.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 116M shares
of 117M outstanding shares and own 99.52% of the company stock.
Largest 10 shareholders include FMR LLC (16.8M shares), VANGUARD GROUP INC (10.3M shares), BlackRock Inc. (7.6M shares), JPMORGAN CHASE & CO (5.87M shares), Rock Springs Capital Management LP (3.8M shares), WELLINGTON MANAGEMENT GROUP LLP (3.79M shares), Bellevue Group AG (3.45M shares), Invesco Ltd. (3.02M shares), Granahan Investment Management, LLC (2.91M shares), and ORBIMED ADVISORS LLC (2.9M shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.